Clinical Trial Update: Growth Differentiation Factor 15 in ICU Acquired Muscle Weakness

View source ↗

Summary

A completed clinical trial evaluating Growth Differentiation Factor 15 in patients with ICU-acquired muscle weakness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness Myopathy
• Critical Illness Polyneuropathy

Snippet

Sponsor: Minia University | Conditions: Muscle Weakness | Status: COMPLETED